B Pfizer News Today

In a lawsuit filed Thursday in state district court in Lubbock County, state Attorney General Ken Paxton accused Pfizer of promoting the vaccine and its boosters by making "unsupported claims."

An autumn chill always precedes the annual period of cold-weather maladies.

The Food and Drug Administration approved updated booster shots for COVID-19 on Monday, a major step toward launching a fall immunization campaign against the virus that is now viewed as a perennial but manageable threat.

Florida Gov. Ron DeSantis, who has staunchly opposed pandemic-related mandates and lockdowns, is seeking a grand jury investigation of potential wrongdoing by the major manufacturers of the COVID-19 vaccine.

Makers of the leading COVID-19 vaccines have launched trials of a two-in-one shot that would attack the coronavirus and influenza, hoping a single shot will be more convenient than a poke in both arms.

A heavily vaccinated-slash-boosted President Biden emerged from his COVID-19 test-positive isolation to advise Americans to wear face masks, get the COVID shot and boosters -- in other words, to do all the things he did but that failed to keep him from catching COVID.

Kids aged 6 months to 5 years old will begin to receive COVID-19 shots in earnest on Tuesday, but the campaign will be centered on pediatrician offices and select pharmacies, giving the rollout a different look than mass efforts for older ages that featured converted gymnasiums and drive-thru centers.

Advisers to the Food and Drug Administration on Wednesday endorsed COVID-19 vaccines for use in kids ages 6 months to 4 years, meaning the youngest Americans should be eligible for the shots by next week.

Children under age 5 should begin receiving COVID-19 vaccines on or around June 21 if the Food and Drug Administration approves the pediatric shots after a mid-month meeting with advisers, said Dr. Ashish Jha, the White House COVID-19 coordinator.

The Biden administration said Thursday it is launching the first federally run test-to-treat site in Rhode Island as it puts its stamp on efforts to disperse a promising antiviral drug against COVID-19.